Comparative Effectiveness on Survival of Zoledronic Acid Versus Pamidronate in Multiple Myeloma

Leukemia and Lymphoma - United Kingdom
doi 10.3109/10428194.2014.924117
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Safe and Tolerable One-Hour Pamidronate Infusion for Multiple Myeloma Patients

Therapeutics and Clinical Risk Management
2008English

Treatments for Newly Diagnosed Multiple Myeloma: Analysis of Survival Data and Cost-Effectiveness Evaluation.

Oncology Reports
MedicineCancer ResearchOncology
1998English

Influence of Body Mass Index on Survival in Veterans With Multiple Myeloma

Oncologist
Cancer ResearchMedicineOncology
2013English

Multiple Myeloma and Fatty Acid Metabolism

JBMR Plus
2019English

Life-Threatening Hypophosphataemia Secondary to Zoledronic Acid Implementation in a Middle-Age Patient Who Presented With Advanced Osteolysis in the Course of Multiple Myeloma

Endokrynologia Polska
EndocrinologyMetabolismDiabetes
2020English

Regulation of Multiple Myeloma Survival and Progression by CD1d

Blood
BiochemistryImmunologyCell BiologyHematology
2009English

PCN66 Cost-Effectiveness of Denosumab Versus Zoledronic Acid for Skeletal-Related Event (SRE) Reduction in Bone-Metastatic Prostate Cancer (mPC) in the UK

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

P2.13-20 the Comparative Effectiveness of Gefitinib Versus Erlotinib on the Intracranial Progression-Free Survival in Patients With Brain Metastasis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Effects of Zoledronic Acid on Odontoblast-Like Cells

Archives of Oral Biology
MedicineOtorhinolaryngologyCell BiologyDentistry
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy